{
  "name" : "dacemirror.sci-hub.se_journal-article_fc615e113438d7a981b3ef2e7012c1f0_guo2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Pulmonary toxicity of inhaled nano-sized cerium oxide aerosols in Sprague–Dawley rats",
    "authors" : [ "Chang Guo", "Sarah Robertson", "Ralf J. M. Weber", "Alison Buckley", "James Warren", "Alan Hodgson", "Joshua Z. Rappoport", "Konstantin Ignatyev", "Kirsty Meldrum", "Isabella Römer", "Sameirah Macchiarulo", "James Kevin Chipman", "Tim Marczylo", "Martin O. Leonard", "Timothy W. Gant", "Mark R. Viant", "Rachel Smith", "Isabella R€ omer" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "ARTICLE HISTORY Received 3 July 2018 Revised 27 November 2018 Accepted 28 November 2018\nKEYWORDS Nanoparticle; cerium; omics; rat; inhalation"
    }, {
      "heading" : "Introduction",
      "text" : "Nanomaterials offer unique mechanical, chemical, electrical and optical properties that are being exploited for an extensive range of applications; however, concerns remain about their potential impact on human health. Cerium oxide nanoparticles (CeO2NPs) are one of the manufactured nanomaterials currently receiving significant attention with respect to their potential health risks as they are used in a range of applications with the potential for direct human exposure, including polishing media (Reed et al. 2014) and fuel-borne catalysts,\nsuch as EolysTM, Platinum PlusTM, and EnviroxTM (Majestic et al. 2010). The benefits of CeO2NP-based fuel additives include reduced emissions of gaseous products of incomplete combustion and improved fuel combustion efficiency (Zhang et al. 2013). However, CeO2NPs have been detected in ambient air in locations where such additives are in use (Park et al. 2008a, Gantt et al. 2015) and there are concerns about their potential impact on health following inhalation (Geraets et al. 2012).\nReported effects of CeO2NPs in vivo following intratracheal instillation include alveolar epithelial hyperplasia, lung inflammation, air-blood barrier damage, and fibrosis of the lungs (Ma et al. 2011;\nCONTACT Chang Guo chang.guo@phe.gov.uk Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0RQ, UK; Rachel Smith rachel.smith@phe.gov.uk Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0RQ, UK.\nSupplemental data for this article can be accessed on the publisher’s website. Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/inan. 2019 Informa UK Limited, trading as Taylor & Francis Group\nMa et al. 2012; Peng et al. 2014; Rice et al. 2015). A number of in vivo inhalation studies have also reported similar effects, with indications that pulmonary inflammatory responses are slow to resolve post-exposure (Aalapati et al. 2014). Inhalation biodistribution studies have also found significant accumulation in pulmonary tissue and slow clearance (Geraets et al. 2012; Li et al. 2016).\nField studies have identified ceria particles emitted from vehicles using the EnviroxTM fuel additive, with a size range from 5 to 100 nm (Gantt et al. 2014). However, to date, the majority of reported CeO2NP inhalation studies, as summarized in Table 1, including those mentioned above, have used aerosols in the micron-size range or at the upper end of the nano-size range and therefore, given the importance of particle size in driving biological effects (Oberd€orster, Ferin, & Lehnert 1994; Braakhuis et al. 2016), may not be directly relevant to a hazard assessment of the effect of ceria particles emitted from engines using CeO2NP fuel additives. The purpose of this study was, therefore, to undertake a short-term in vivo inhalation study using a ceria aerosol with a more environmentally relevant aerosol particle size, to investigate the effects on lung inflammation and injury. It was anticipated that comparing the results of this study with those in the literature, which have all used significantly larger aerosol particle sizes, would provide support for the hypothesis that aerosol particle size is an important toxicity driver.\nWe also utilized a multi-omics approach – applying microarray-based gene expression profiling and untargeted mass spectrometry-based lipidomics – to enable a broad measurement of thousands of molecular endpoints to provide insights into the toxicity mechanisms of CeO2NPs (Taylor et al. 2016; Dekkers et al. 2018). Furthermore, we assessed the distribution of inhaled CeO2NPs in various organs and their physicochemical properties using a range of approaches. Many studies have indicated that the physicochemical properties of nanomaterials have a significant influence on their biological activity. CeO2NPs are an interesting case as it has been hypothesized that initial differences in the Ce3þ/ Ce4þ ratio on the NP surface, and changes in their anti-oxidant potential following exposure, may play a significant role in toxicity determination (Auffan et al. 2009). To explore this, synchrotron-based\nspectroscopy was applied to determine cerium oxidation states in exposed lung tissues."
    }, {
      "heading" : "Materials and methods",
      "text" : ""
    }, {
      "heading" : "Cerium oxide nanoparticles",
      "text" : "CeO2NPs (primary particle size 8 nm) were provided by the University of Birmingham. Details of the synthesis are described in the Supplementary information (Chen et al. 2013). The powder was dispersed in MilliQ water (1mg/mL) and sonicated briefly ( 1min) prior to use.\nExposure system and aerosol characterization\nThe nose-only inhalation exposure system and the aerosol characterization undertaken are described in the Supplementary information. Details of the dose estimation method are also described in the Supplementary information."
    }, {
      "heading" : "Study design",
      "text" : "The experiments were performed within the legal framework of the United Kingdom under a Project License granted by the Home Office of Her Majesty’s Government. All procedures involving the animals were performed in accordance with the Animals (Scientific Procedures) Act 1986. Male Sprague–Dawley (SD) rats (10–12weeks, 250–320 g) were purchased from Harlan, UK. Rats were randomly assigned into groups and exposed to aerosolized CeO2NPs or water (controls) for 3 h per day, for 4 d per week, for 1 or 2 weeks. The 2-week exposure was chosen to explore the effect of a higher deposited dose within the lung, an alternative approach of using a higher aerosol concentration was discounted as this would have affected the aerosol particle size. Following exposure, the rats were returned to their cages for a period of either 3 d, to characterize the initial response, or 7 d to explore recovery and other effects in the shortterm. Assessment of adverse clinical signs is described in the Supplementary information.\nAnalysis of bronchoalveolar lavage fluid (BALF)\nRats were sacrificed by exsanguination by cardiac puncture under isoflurane anesthesia (induced at\n5%, maintained at 1.5–2% in 100% oxygen). Bronchoalveolar lavage was performed in situ via tracheal cannula with 2 7mL aliquots of phosphate buffered saline (PBS). Cells from both aliquots were pooled for cytological analysis as described in the Supplementary information. BALF supernatants from the first wash were collected for analysis of cytotoxicity and alveolar barrier damage as described in the Supplementary information.\nCytokines and chemokines including IL-1b (interleukin-1b), TNF-a (tumor necrosis factor-a), TFG-b1 (transforming growth factor-b1), CXCL2 (CINC-3, cytokine-induced neutrophil chemoattractant 3), CXCL1 (CINC-1, cytokine-induced neutrophil chemoattractant 1), and CCL2 (MCP-1, monocyte chemoattractant protein-1) were measured in BALF supernatants using R&D Systems QuantikineVR ELISA kits according to the manufacturer’s specifications."
    }, {
      "heading" : "Lung tissue processing",
      "text" : "Following lavage, the apical and azygous lung lobes were tied off and snap frozen in liquid nitrogen for multi-omics analysis. The remainder of the lungs was removed and inflated and fixed with freshly made 4% paraformaldehyde via tracheal cannula, at a pressure of 30 cm of water and then processed into paraffin blocks. Cross/transverse sections of lung tissues chosen randomly were cut at a thickness of 5 lm before mounting onto microscope slices. For histopathology, staining with hematoxylin and eosin (H&E) was performed on lung tissue sections."
    }, {
      "heading" : "Multi-omics analysis of lung",
      "text" : "Lung tissues were homogenized in 8mL/g (v/w wet mass) methanol and 2.5mL/g (v/w) water using a bead-based homogenizer (Precellys 24; Stretton Scientific, Stretton, UK). Lung homogenate aliquots were then taken for both metabolite and RNA extractions. Total RNA was isolated using Qiagen’s mini RNeasy Kit and QIAshredder (Qiagen, Crawley, UK) according to the manufacturer’s protocol. RNA was quantified with a NanoDrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA), and the integrity of RNA was verified with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Lipids from the lung homogenate were extracted\nusing a methanol:water:chloroform (2:2:1.8) solvent system (Wu et al. 2008), dried using a centrifugal concentrator and stored at –80 C until analysis.\nMicroarray-based gene expression profiling was performed according to the manufacturer’s protocol (Agilent Technologies, Santa Clara, CA). Further details are described in the Supplementary information. Mass spectrometry-based lipidomics was performed using a high-resolution spectral-stitching nanoelectrospray direct-infusion approach as previously reported (Southam et al. 2017). Further details are described in the Supplementary information.\nCerium in tissues determined by ICP-MS and laser ablation ICP-MS\nThe cerium content of liver and kidney samples was determined using inductively coupled plasma mass spectrometry (ICP-MS) as described in the Supplementary information. Elemental mapping of cerium in lung tissue samples was undertaken by laser ablation ICP-MS using a New Wave Research NWR213 laser ablation system (Electro Scientific Industries, Portland, OOR) linked to an iCAP Q ICPMS (Thermo Fisher Scientific, Hemel Hempstead, UK). Further details are described in the Supplementary information."
    }, {
      "heading" : "Transmission electron microscopy (TEM)",
      "text" : "Lung tissues from animals at 3 d after 2-week exposure (CeO2NP exposed and control) were prepared as described in the Supplementary information and TEM imaging was then performed using an FEI Tecnai Spirit G2.\nSynchrotron-based X-ray spectroscopy\nSynchrotron microfocus X-ray spectroscopy was carried out at the Diamond Light Source I18 Beamline (Oxfordshire, UK). Microfocus X-ray fluorescence (l-XRF) analysis was undertaken to provide information on the spatial distribution of elements of interest for a number of lung sections. For identified areas of high cerium concentration, X-ray absorption near-edge structure (XANES) spectrometry of the Ce LIII-edge was carried out to investigate chemical speciation (e.g. oxidation state). The spectra produced were compared with those for\nsamples of some cerium compounds: Ce2(CO3)3, Ce(OH)4 (Sigma-Aldrich, St. Louis, MO), and CeO2 (Acros Organics, Morris, NJ), and a sample of the CeO2NPs. Further details are described in the Supplementary information."
    }, {
      "heading" : "Results",
      "text" : ""
    }, {
      "heading" : "Aerosol characterization",
      "text" : "Aerosol characteristics and lung dose estimates are presented in Table 2 and Figure 1, including\nrepresentative images of agglomerated CeO2NP aerosol particles, illustrating their spherical form and primary particle size consistent with the manufacturer’s data (ca 8 nm) (Chen et al. 2013).\nAcute pulmonary toxicity effects induced by inhaled CeO2NPs\nInhalation exposure to CeO2NPs did not affect the body weight development of the rats (data not shown). No adverse clinical signs were observed in any of the animals.\nFigure 1. (A) CeO2NP aerosol particle size distribution. (B–D) Transmission electron microscope images of CeO2NP aerosol particles illustrating clear crystalline form (D).\nFigure 2. Comparison of changes in BALF parameters after 1 week (A) and 2 weeks (B) of exposure to CeO2NP aerosols. Changes are shown as fold differences compared to controls (H2O aerosols) using logarithmic scaling (MPH: macrophages; PMN: neutrophils; LYMPH: lymphocytes; LDH: lactate dehydrogenase; ALP: alkaline phosphatase).\nCytology and cytotoxicity analysis of bronchoalveolar lavage fluid (BALF)\nBALF analysis was undertaken at 3 d and 7d postexposure for both 1-week and 2-week exposure groups. The majority of BALF parameters showed significant increases for CeO2NP exposed groups compared to the control groups (Figure 2, with details presented in Supplementary Figures S2 and S3). For the 1-week exposure group, there was a small but significant increase in the different cell populations between 3 and 7d post-exposure, although the levels of total protein, lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) showed a reduction over this period indicating limited recovery. For the 2-week exposure group, there was no significant change in the total protein, LDH or ALP levels between 3 and 7d post-exposure, but significant increases in the different cell populations. The above indicates that the inhaled CeO2NPs induced time- and dose-dependent inflammation and lung damage."
    }, {
      "heading" : "Cytokines/chemokines in BALF",
      "text" : "Effects on several cytokines and chemokines relevant to inflammatory responses and allergic effects were considered. There was no significant change in IL-1b concentrations for any exposed group (Figure 3(A)), whereas for TNF-a and TFG-b1 there were significant increases in some groups (Figure 3(B,C)). For CXCL2, CXCL1, and CCL2, there were significant increases for all exposed groups (Figure 3(D–F)). The effects were the greatest for CXCL1 and CCL2, for which there was a clear dose-dependent effect at both post-exposure times. There was also some indication of concentrations increasing with time post inhalation, although this was only significant for CCL2 for the 1-week exposure. For the others, patterns were less clear, with CXCL2 showing no dose- or time-dependence, TGFb1 showing no time-dependence and dose-dependence for the 7-d groups only, and TNF-a showing dose-dependence for the 3-d groups only and timedependence for the 1-week exposure groups only.\nFigure 3. Cytokine levels in BALF from rats exposed to H2O or CeO2NP aerosols. (A) IL-1b, (B) TNF-a, (C) TFG-b1, (D) CXCL2/CINC3, (E) CXCL1/CINC-1, and (F) CCL2/MCP-1. Data shown as mean± SD (n¼ 5 rats for groups exposed to CeO2NP aerosols and n¼ 3 for control groups exposed to H2O aerosols). p< 0.05, p< 0.01, p< 0.001.\nHistopathology – lung inflammatory changes\nInhalation of CeO2NPs resulted in mild inflammation for both exposure durations and at both 3 and 7 d\npost-exposure (Figure 4). The lung architecture was well preserved with inhaled CeO2NPs but minor alveolar epithelial hyperplasia with accumulation of eosinophilic materials from macrophage breakdown\nFigure 4. Representative hematoxylin and eosin stained lung sections ( 200, inset 400) from rats of negative controls (A and B) and CeO2NP aerosol exposure at 3 d (C and D) and 7d (E and F) post-exposure (A, C, E, 1-week exposure; B, D, F, 2-week exposure). Symbols indicate some histopathological observations including infiltration of inflammatory cells (black arrows), deposition of amorphous eosinophilic materials (diamond arrows), alveolar wall injury (open arrows) and minor alveolar epithelial hyperplasia (areas inside black circles).\nFigure 5. Principal component analysis (PCA) score plots of the gene expression (A) and lipidomics profiles (B) of lung tissue from rats exposed to H2O and CeO2NP aerosols for 1 week and 2 weeks at 3 d post-exposure.\nFigure 6. Representative laser ablation inductively coupled plasma mass spectrometry elemental maps (isotopes 13C and 140Ce) and light microscopy images ( 12.5) of lung tissues of negative controls (images A–C) and CeO2NP aerosol exposed animals at 3 days (images D–F) and 7 d (images G–I) post-exposure. The light microscope images show the lung tissue section prior to undertaking laser ablation (which destroys the sample) and allow the overall shape and structures such as large airways and larger blood vessels to be seen for comparison purposes.\nFigure 7. Transmission electron microscope images of lung tissue from rats exposed to H2O aerosols (A) and CeO2NP aerosols (B) for 2 weeks at 3 d post-exposure. The boxes with dotted lines denote the approximate locations of the corresponding magnified regions.\nwas observed. The lung injury induced by CeO2NPs appeared to increase with time for 1-week exposure based on the histopathological observations."
    }, {
      "heading" : "Multi-omics analysis of lung",
      "text" : "Principal component analysis (PCA) score plots from the analysis of the gene expression and lipidomics measurements are shown in Figure 5. For the gene expression analysis, the score plot captured 53.6%\nof the variation in the dataset within the first two components; a significant separation between rats exposed to H2O aerosols and CeO2NP aerosols was discovered along PC1 (t-test of the scores values: p¼ 4.0 10 3, Figure 5(A)), confirming that the NP exposure induced perturbations to gene transcription. The PCA score plot derived from the lipidomics data captured 55.6% of the variation in the first two components, and also showed a significant separation between control and CeO2NP aerosols, in this case along PC2 (t-test of the scores values: p¼ 8.5 10 4, Figure 5(B)). Limma was applied to the gene expression data to investigate the effects of CeO2NP exposure (H2O aerosol exposure as the controls) and it was found to be statistically significant with CeO2NP exposure (q< 0.05 and log2-fold change >1.0) for 67 genes (Supplementary Table S1). DAVID analysis on the 67 differentially expressed genes (of which 53 were matched to a gene present in DAVID) yielded 13 GO-categories that were significantly enriched (q< 0.05, Supplementary Table S2).\nFor the lipidomics data, two-way ANOVA (type II, unbalanced) was conducted on each peak to investigate the effects of inhaled CeO2NPs and exposure dose (1-week versus 2-week exposure). CeO2NP inhalation was statistically significant for 38 peaks (q< 0.05) of which 19 where putatively annotated with a lipid name from the Lipid Maps database (Supplementary Table S3 and Supplementary File SI1). Exposure dose had no significant effect on any of the peak intensities. Enrichment analysis of categorical annotations of the significant and annotated lipids was conducted, using MBROLE (LopezIbanez, Pazos, & Chagoyen 2016) (Supplementary Table S4) and LIPID Metabolites And Pathways Strategy (LIPID MAPSVR ), and revealed that several lipid classes (e.g. glycerophospholipids) and subclasses (e.g. diacylglycerophosphocholines, glycerophosphoethanolamines, and diacylglycerophosphoethanolamines) were significantly enriched."
    }, {
      "heading" : "Assessment of the inhaled CeO2NPs",
      "text" : "Detection of CeO2NPs deposited in the lung\nElemental maps of lung tissues produced by laser ablation ICP-MS clearly indicate the presence of\nFigure 8. (A) XANES Ce LIII spectra for cerium standard samples of Ce2(CO3)3, Ce(OH)4, and CeO2. (B–C) XANES Ce LIII spectra derived from cerium-rich pixels of elemental m-XRF maps of lung tissue sections from rats exposed to the CeO2NP aerosols for two weeks at 3 d (B, A combination of 4 pixels) and 7 d (C, A combination of 6 pixels) post-exposure. The top right-hand corner images in B and C are the associated elemental m-XRF maps of cerium in lung tissue samples from animals post-exposure. Data obtained using the I18 beamline at the Diamond Light Source (pixel size 4mm 4mm).\ncerium, widely distributed within the lung lobes, without any significant association with the larger airways or larger blood vessels (Figure 6). TEM micrographs (Figure 7) indicate the presence of dense particle agglomerates of similar size to the CeO2NP aerosol agglomerates in the alveolar macrophages, mainly in the lysosome-like intracellular vesicles."
    }, {
      "heading" : "Cerium in liver and kidney",
      "text" : "The concentrations of cerium in the liver and kidney were measured by ICP-MS and were greater in exposed than control animals, higher for 2-week than 1-week exposure, and increased from 3d to 7 d post-exposure, indicating the translocation of cerium from the lung to other organs after inhalation, however, these changes were only statistically significant for some groups (Supplementary Figure S5).\nCerium speciation by synchrotron X-ray spectroscopy\nCerium LIII XANES spectra of the cerium compounds Ce2(CO3)3, CeO2, and Ce(OH)4 are shown in Figure 8(a). Both Ce4þ compounds (CeO2, and Ce(OH)4) show a doublet peak of roughly equal height, whereas the Ce3þ carbonate (Ce2(CO3)3) shows a clearly different peak morphology. The XANES spectrum for the CeO2NP sample appears qualitatively similar to the Ce4þ compounds (Supplementary Figure S6). A linear combination fitting (LCF) analysis was carried out for the CeO2NP spectrum using the spectra from the cerium compounds as standards. The fit analysis indicated that the CeO2NP sample was 100% CeO2 with zero contributions from the other standards.\nCerium mapping of lung tissue sections from exposed rats was undertaken using l-XRF, and XANES spectra collected from identified areas of high cerium concentration (Figure 8(B,C)). Quantitative LCF analysis was carried out in each case, using the standards’ spectra. The results indicated 21% Ce3þ carbonate and 79% Ce4þ oxide at 3 d and 15% Ce3þ carbonate and 85% Ce4þ oxide at 7 d post-exposure. In comparison to the 100% Ce4þ in the aerosol NPs, these results indicate changes to cerium speciation in the lung following inhalation; however, given the limited sample\nnumbers, it is not possible to judge whether the difference between 3 and 7 d is significant."
    }, {
      "heading" : "Discussion",
      "text" : "We have investigated the pulmonary toxicity of nano-sized CeO2NP aerosol agglomerate particles (CMD approximately 40 nm, GSD 1.7; primary particle size 5–10 nm). Histopathology indicated mild inflammation with alveolar epithelial hyperplasia (Figure 4), which increased with time after exposure, suggesting the potential for long-term effects. Consistent with this the BALF analysis indicates a significant inflammatory response increasing between 3 and 7 d (Figure 2 and Supplementary Figures S2 and S3). These changes were matched by significant increases in cytokines involved in inflammatory cell infiltration, such as CXCL1(CINC-1) and CCL2(MCP-1) (Figure 3), with levels increasing with dose for each post inhalation time (dosedependence). Concentrations of total protein, LDH, and ALP in BALF increased significantly for all groups exposed to CeO2NP aerosols (Figure 2 and Supplementary Figures S3) with some evidence of recovery only for the 1-week exposures, again suggesting the potential for longer-term effects. The gene expression results (Supplementary Table S2) are consistent with the above, with significant Gene Ontology terms including (GO:0030593) neutrophil chemotaxis, (GO:0048247) lymphocyte chemotaxis, (GO:0008009) chemokine activity, and (GO:0002548) monocyte chemotaxis.\nOther CeO2NP inhalation studies have also shown lung inflammation, cytotoxicity, and airblood barrier damage;, however, the majority of such studies have used aerosols with micron-sized aerosol agglomerates (Table 1), significantly larger than used in this study, and the resulting effects are typically less marked than indicated here. To achieve similar or relatively comparable toxicological effects, inhalation studies with micron-sized CeO2NP aerosols usually used higher aerosol concentrations or longer exposure durations (Table 1). Landsiedel et al. (2014), for example, used a similar short-term repeated exposure study design (6 h/d for 5 d with sacrifice at 3 d) with a micron-sized aerosol, which at the low concentration (0.8mg/m3) delivered a very similar ‘exposure dose’ (i.e. concentration duration) to our one week exposure, and yet\nTa bl e 1.\nSu m m ar y of\nin ha la tio\nn to xi ci ty\nst ud\nie s w ith\nCe O 2N Ps .\nCh ar ac te riz at io n of\npr im ar y pa rt ic le s\nCe O 2 pa rt ic le s\nPr im ar y pa rt ic le di am et er (n m )\nSu rf ac e ar ea\n(m 2 / g)\nCh ar ac te riz at io n of\nae ro so ls (M\nM AD – m as s m ed ia n ae ro dy na m ic di am et er ; G SD – ge om et ric st an da rd de vi at io n; CM D – co un t m ed ia n di am et er ;G\nM D –\nge om\net ric\nm ea n di am\net er )\nEx po\nsu re\ndo se\n(a er os ol co nc en tr at io n ex po su re\ndu ra tio\nn) An\nim al\nm od\nel s\nAn im al\nsa cr ifi ce\ntim e po\nin ts po st -e xp os ur e\nBr ie f bi ol og\nic al\nfin di ng\ns\nRe fe re nc e ( no\nse -o nl y\nin ha la tio\nn;\nw ho\nle -b od y ex po su re )\nCe O 2N Ps (N an oA\nm or ph\n) 15 -3 0 (m\nan uf ac tu re r) ,\n55 (S EM\n) 30 -5 0 (m\nan uf ac tu re r)\nM M AD\n(µ m )/ G SD\n2. 28 /2 .9 4\n64 1 m g/ m\n3 × 4 hr s\nW is ta r ra ts\n1, 2 an d 14\nd po\nst Si gn\nifi ca nt\ncy to to xi ci ty ,o\nxi da tiv e st re ss\nan d in fla m m at io n in\nth e lu ng\ns. (S rin\niv as\net al .,2 01 1)\n*\nCe O 2N Ps (N M - 21 1)\n(A nt ar ia );\n5- 10\n(m an uf ac tu re r) , 13 .0 ± 3. 2 (T EM ), 44 .9 ± 14 .6 (S EM\n);\n63 .9 5 ± 0. 30 ;\nM M AD\n(µ m )/ G SD\n1. 02\n± 0. 04\n/1 .8 2;\n10 .7 9 ± 0. 82\nm g/ m\n3 × 40\nm in /\nd, 2 h/ d or\n6 h/ d × 1 d or 5 d/ w k × 2 w ks or 4 w ks ;\nW is ta r ra ts\n6 h/ d gr ou\nps on\nly - 1 d po st pl us 2/ 3 d po st th e 4- w k ex po su re gr ou ps\nTh er e w as\nno cl ea r ef fe ct\nof th e pr im ar y\npa rt ic le\nsi ze\nor su rf ac e ar ea\non pu lm on ar y de po si tio n an d ex tr ap ul m ona ry tis su e di st rib ut io n.\n(G er ae ts\net al .,2 01 2)\n*\nCe O 2N Ps (N M -2 12 ) (U m ic or e) ; 40\n(m an uf ac tu re r) , 27 .3 ± 13 .6 (T EM ), 28 .4 ± 10 .4 (S EM );\n27 .1 5 ± 0. 19 ;\nM M AD\n(µ m\n)/ G SD\n1. 17\n± 0. 34 /2 .0 7;\n19 .9 5 ± 13 .2 1 m g/ m\n3 ×\n40 m in /d ,2\nh/ d or\n6 h/ d ×\n1 d or\n5 d/ w k × 2 w ks or 4 w ks ;\n4- w k gr ou\nps on\nly - 1 d po st al le xp os ur e gr ou ps ,a nd 28 d po st th e 6 h/ d gr ou ps\nAl lt hr ee\nm at er ia ls ga ve\nris e to\nsi m ila r\nle ve ls of\npu lm on\nar y in fla m m at io n,\nw ith\ndo se -d ep en de nt\nin cr ea se s in\nto ta lc el ln\num be rs ,m\nac ro ph\nag es ,\nne ut ro ph\nils an d ly m ph\noc yt es in BA LF .S ys te m ic ef fe ct s w er e vi rt ual ly ab se nt .\n(G os en s et\nal .,2 01 4)\n*\nCe O 2 (N M -2 13 ) (S ig m a)\n< 50 00\n(m an uf ac tu re r) , 61 5. 3 ± 43 0. 5 (S EM\n) 3. 73\n± 0. 01 ;\nM M AD\n(µ m ) /G SD\n1. 40\n± 0. 11 /1 .6 4\n55 .0 0 ± 6. 2 m g/ m\n3 × 40\nm in /\nd, 2 h/ d or\n6 h/ d × 1 d or 5 d/ w k × 2 w ks or 4w ks\nCe O 2N Ps\n(u nc oa te d) (p ro du ce d in -h ou se );\n17 .3\n(X RD ), 12 .8 (B ET\neq ui va -\nle nt\ndi am\net er );\n61 ;\nCM D (n m )/ G SD\n89 .5 ± 7. 8/\n1. 55\n± 0. 05 ,M\nM AD\n(n m )/ G SD\n28 1/ 3. 09 ;\n2. 7 m g/ m\n3 × 2 h/ d × 4 d\nSp ra gu eD aw\nle y ra ts\n1 d po\nst Ex po\nsu re\nto un\nco at ed\nCe O 2N Ps\nca us ed\nlu ng\nin ju ry\nan d in fla m m at io n w ith\nin cr ea se d PM\nN an d LD\nH le ve ls in\nth e\nBA LF\nof th e ra ts ,w\nhe re as\nex po\nsu re\nto Si O 2- co at ed\nCe O 2N Ps\ndi d no t in du ce an y pu lm on ar y to xi ci ty .\n(D em\nok rit ou et al .,2 01 3)\n**\nSi O 2- co at ed\nCe O 2N Ps\n(p ro du\nce d\nin -h ou\nse )\n21 (X RD\n), 19 .2\n(B ET\neq ui va le nt\ndi am\net er )\n50 CM\nD (n m )/ G SD 10 0. 4 ± 5. 2/ 1. 48 1 ± 0. 00 6, M M AD (n m )/ G SD 34 1/ 5. 02\nCe O 2N Ps (N an oA\nm or ph\n) 15 -3 0 (m\nan uf ac tu re r) ,\n45 (T EM\n) 30 -5 0 (m\nan uf ac tu re r) ,\n56 ± 25\n(B ET )\nM M AD\n(µ m )/ G SD\n1. 4/ 2. 4\n2. 0 ± 0. 03 5 m g/ m\n3 × 6 h/ d ×\n0, 7,\n14 ,2\n8 d\nCD 1 ra ts\n1 d po\nst al le\nxp os ur e gr ou\nps ,\nan d 14\nan d 28\nd po\nst 28 -\nd ex po\nsu re\ngr ou\np\nIn ha la tio\nn ex po\nsu re\nof Ce O 2 N Ps\nin du\nce d si gn\nifi ca nt\npu lm on\nar y an d\nso m e ex tr ap ul m on\nar y to xi ci ty .\n(A al ap at ie\nt al .,2 01 4)\n*\nCe O 2N Ps (N an oC\nar e\npr oj ec t) ;\n0- 20 0 (T EM\n), > 10\n× 10\n3\n(S EM\n), 36\n(X RD\n); 33 .0 ;\nM M AD\n(µ m )/ G SD\n0. 6/ 2. 4,\n0. 9/ 2. 3,\n0. 8/ 2. 5;\n0. 8,\n3. 0,\n11 .6 m g/ m\n3 × 6 h/ d\n× 5 d;\nW is ta r ra ts\n3 an d 24\nd po\nst fo r al le\nxp os -\nur e gr ou\nps In ha le d Ce O 2N Ps\nan d Al -d op\ned Ce O 2N Ps\nca us ed\na tr an si en t, co nc en tr at io n-\nde pe nd\nen t in fla m m at io n of\nth e lu ng\nat al lc on\nce nt ra tio\nns .\n(L an ds ie de le\nt al .,2 01 4)\n*\nAl -d op\ned Ce O 2N Ps\n(N an oC\nar e\npr oj ec t)\n2- 16 0 (T EM\n), > 20\n× 10\n3\n(S EM\n), 23\n(X RD\n) 46 .0\nM M AD\n(µ m )/ G SD\n1. 3/ 2. 1,\n2. 2/ 1. 9,\n2. 4/ 2. 1\n0. 6,\n2. 1,\n9. 2 m g/ m\n3 × 6 h/ d ×\n5 d\nCe O 2N Ps\n(N M -2 11 )\n(B AS\nF SE );\n4- 15\n(T EM\n), 12 .5\n(X RD\n) 33\n(H g) ,5\n3 (B ET )\nM M AD\n(µ m )/ G SD\n1. 9/ 2. 9,\n2. 2/ 2. 4\n0. 45\n± 0. 1,\n25 .8 ± 1. 7 m g/ m\n3\n× 6 h/ d × 5 d/ w\n× 1 w k\nW is ta r ra ts\n1- w k gr ou\nps - BA\nLF at\n3 an d\n24 d po\nst an d hi st op\nat h-\nol og\ny an d or ga n bu\nrd en\nat 0 an d 21\nd po\nst .4\n-w k\ngr ou\nps - BA\nLF 1 an d 35 d po st ,h is to pa th ol og y at 2 an d 34 d po st an d lu ng bu rd en at 7 tim e po in ts to 12 9 d po st\nIn ha le d Ce O 2N\nPs cl ea re d fr om\nth e lu ng\nw ith\na ha lftim\ne of\n40 d at\na co nc en tr a-\ntio n of\n0. 5 m g/ m\n3 , at\nhi gh\ner co nc en tr a-\ntio ns\ncl ea ra nc e w as\nim pa ire d.\nD os e-\nde pe nd\nen t in fla m m at or y re sp on\nse do\nm i-\nna te d by\nne ut ro ph\nils fo r 1 w ee k ex po - su re s an d m ac ro ph ag es fo r 4- w ee k ex po su re s. Th e in fla m m at or y re sp on se co rr el at ed be tt er w ith th e su rf ac e ar ea do se th an m as s or vo lu m e do se s. 5 m g/ m 3 w as th e lo w es t ae ro so lc on ce nt ra tio n at w hi ch th e ea rly as w el la s th e la te r in fla m m at or y re sp on se w as ob se rv ed .\n(K el le r et\nal .,2 01 4)\n**\nCe O 2N Ps\n(N M -2 12 )\n(N an oM\nile pr oj ec t)\n40 (T EM\n), 3- 15 0 × 10\n3\n(S EM\n), 40 .0\n(X RD\n); 30\n(H g) ,2\n7 (B ET );\nM M AD\n(µ m )/ G SD\n1. 4/ 2. 3,\n1. 2/ 2. 1,\n1. 0/ 2. 5;\n0. 5 ± 0. 2,\n5. 3 ± 0. 9,\n25 .9 ± 6. 0\nm g/ m\n3 × 6 h/ d × 5 d/ w k × 1 w k;\nM M AD\n(µ m )/ G SD\n1. 6/ 2. 1,\n1. 3/ 2. 1,\n0. 9/ 2. 5;\n0. 48\n± 0. 0,\n5. 2 ± 1. 1,\n25 .6 ± 6. 0 m g/ m\n3 × 6 h/ d × 5\nd/ w k × 4 w ks ;\n7. 8 (T EM\n); 10 .0\n(D LS );\n10 1 (B ET )\nFi sh er\n34 4 ra ts\n3 d,\n1 an d 3 m on\nth s po\nst (M\nor im ot o et\nal .,2 01 5)\n** (c on tin ue d)\nTa bl e 1.\nCo nt in ue d.\nCh ar ac te riz at io n of\npr im ar y pa rt ic le s\nCe O 2 pa rt ic le s\nPr im ar y pa rt ic le di am et er (n m )\nSu rf ac e ar ea\n(m 2 / g)\nCh ar ac te riz at io n of\nae ro so ls (M\nM AD – m as s m ed ia n ae ro dy na m ic di am et er ; G SD – ge om et ric st an da rd de vi at io n; CM D – co un t m ed ia n di am et er ;G\nM D –\nge om\net ric\nm ea n di am\net er )\nEx po\nsu re\ndo se\n(a er os ol co nc en tr at io n ex po su re\ndu ra tio\nn) An\nim al\nm od\nel s\nAn im al\nsa cr ifi ce\ntim e po\nin ts po st -e xp os ur e\nBr ie f bi ol og\nic al\nfin di ng\ns\nRe fe re nc e ( no\nse -o nl y\nin ha la tio\nn;\nw ho\nle -b od y ex po su re )\nCe O 2N Ps\n(W ak o\nCh em\nic al\nLt d)\nG M D (n m ) 11 0 ± 12 .5\n(h ig h do\nse ),\n87 .6 ± 7. 9 nm\n(lo w\ndo se )\n10 .2 ± 1. 38\nm g/ m\n3 (h ig h do\nse )\nan d 2. 09\n± 0. 29\nm g/ m\n3 (lo w do se ) × 6 h/ d × 5 d/ w k × 4 w ks\nCe O 2N Ps\n(e ith\ner th ro ug\nh in ha la tio\nn or\nin tr at ra ch ea li ns til la tio\nn) in du\nce d no t on ly ac ut e bu t al so ch ro ni c in fla m - m at io n in th e lu ng\n. Ce O 2N Ps (p ro du ce d in -h ou se ) 2- 3 (T EM ); 6. 67 ± 0. 06 (X RD ) N /A G M D (n m ) 14 6 (fr es h 1) ,1 95 (fr es h 2) ,1 74 (a ge d 1) ,1 51 (a ge d 2) 17 2 (fr es h 1) ,5 85 (fr es h 2) , 48 3 (a ge d 1) ,a nd 43 9 (a ge d 2) μ g/ m 3 × 4 hr s Sp ra gu eD aw le y ra ts 15 m in ,1 d an d 7 d po st Th e bi od is tr ib ut io n of\nfr es h an d ag ed\nCe O 2N Ps\nfo llo w ed\nth e sa m e pa tt er ns ,\nw ith\nth e hi gh\nes t am\nou nt s re co ve re d\nin th e fa ec es\nan d lu ng\ns.\n(L ie\nt al .,2 01 6)\n*\nCe O 2N Ps\n(E vo ni kD eg us sa )\n13 .0 ± 12 .1\n56 .7\nG M D (n m ) 37 2 (h ig h do\nse ), 29 5\n(lo w\ndo se )\n8, 30 ,1\n52 m g/ m\n3 × 60\nm in\nBA LB /c J m ic e\n24 hr s an d 13\nw ks\npo st\nBA LF\nce ll an al ys es\nre ve al ed\nbo th\nne ut ro -\nph ili c an d ly m ph\noc yt ic in fla m m at io n\n24 h po\nst ex po\nsu re .C\neO 2 ga ve\nris e\nto a m or e pe rs is te nt\nin fla m m at io n;\nbo th\nne ut ro ph\nili c an d ly m ph\noc yt ic\nin fla m m at io n w as\nse en\nat 13\nw ee ks\npo st .\n(L ar se n et\nal .,2 01 6) **\nCe O 2N Ps\n(p ro du\nce d\nin -h ou\nse )\n4. 7 ± 1. 4 (T EM\n) N /A\nCM D (n m )/ G SD\n18 2 ± 10 /1 .8 8\n3. 98\n± 0. 23\nm g/ m\n3 × 3 h/ d ×\n5 d/ w k × 4 w ks\nC5 7B L/ 6J\nm ic e (A po\nE/- )4\nw ks\npo st\nCe O 2N\nP ex po\nsu re\nha d no\nm aj or\nto xi co -\nlo gi ca la\nffe ct s ap ar t fr om\nm od\nes t\nin fla m m at or y hi st op\nat ho\nlo gy in th e lu ng .\n(D ek ke rs et\nal .,2 01 7) *\nCe O 2N Ps\n(N M -2 12 )\n(p ro vi de d by\nFh -IM\nE) 28 .4\n27 .2\n(B ET )\nM M AD\n(µ m )/ G SD\n0. 71 /3 .5 9,\n0. 63 /\n3. 83 ,0\n.6 8/ 4. 32 ,0\n.7 9/ 3. 50\n0. 1,\n0. 3,\n1. 0 an d 3. 0 m g/ m\n3 ×\n6h /d\n× 5d /w\nk × 1,\n28 ,9\n0 d\nW is ta r ra ts\n1 d\npo st\nal le\nxp os ur e gr ou\nps ,\nan d 28\nan d 90\nd po\nst 90 -\nd ex po\nsu re\ngr ou\np\nLu ng\nbu rd en\nva lu es\nin cr ea se d w ith\nin cr ea si ng\nna no\npa rt ic le\ndo se\nle ve ls\nan d on\ngo in g ex po\nsu re .C\neO 2N Ps\npe ne tr at e th e al ve ol ar\nsp ac e an d\naf fe ct\nth e re sp ira to ry\ntr ac t m ai nl y in\nte rm\ns of\ndo se -d ep en de nt\nin fla m m a-\ntio n,\nw ith\npo st -e xp os ur e pe rs is te nc e.\n(S ch w ot ze r et\nal .,2 01 7)\n*\n1 d po\nst Ch\nan ge s in\nge ne\nex pr es si on\nin AE\nII ce lls\n(3 0 of\n39 1 ge ne s in ve st ig at ed ) in di -\nca te\nth at\nth e ce lls\nco nt rib\nut e to\nCe O 2N P ca us ed\nin fla m m at or y an d\nox id at iv e st re ss\nre ac tio\nns in\nth e\nre sp ira to ry .\n(S ch w ot ze r et\nal .,2 01 8)\n*\nCe O 2N Ps\n(p ro du\nce d\nin -h ou\nse )\n8 nm\n(T EM\n) N /A\nCM D (n m )/ G SD\n43 .4 /1 .7 0 (1 -w k\nex po\nsu re ); 43 .8 /1 .7 2 (2 - w k ex po su re )\n1. 8 m g/ m\n3 × 3 h/ d × 4 d/ w\n× 1 w k or\n2 w ks\nSp ra gu\neD aw\nle y ra ts\n3 an d 7 d po\nst Sh or tte rm\nin ha la tio\nn ex po\nsu re\nto na no - si ze d Ce O 2N P ag gl om er at es in du ce d a si gn ifi ca nt pu lm on ar y in fla m m at or y ef fe ct w ith a lim ite d re so lu tio n by 7 d po st -e xp os ur e.\nTh e pr es en t st ud\ny\ntheir results at this concentration indicate a significantly lower response, with small but significant changes for only three endpoints, including neutrophil and lymphocyte number but not LDH. Only at the medium and high concentrations, delivering exposure doses >4 times higher, were significant changes seen, similar to those here. Keller et al. (2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study. However, it was only at the medium and high concentrations, delivering exposure doses >5 times higher than our study, that a broad pattern of changes was seen, similar to the results presented here. It is clearly more difficult to make direct comparisons with the results from studies with longer exposure durations; however, it is instructive to note that levels of CCL2(MCP-1), which were significantly enhanced in this study, were only significantly enhanced in a 28-d study (6 h/d, 5 d/ week, 4weeks) (Schwotzer et al. 2017, 2018) at the two highest concentration levels, which would have resulted in exposure doses >3 times higher than this study, and for neutrophil numbers and LDH levels only the highest concentration (3mg/m3), delivering an exposure dose 9 times greater, produced similar effects to those reported here. Schwotzer et al. (2018) also assessed the effect of exposure on the expression of 391 genes in alveolar epithelial type II cells and identified significant regulatory changes to a total of 30 genes, many of which (e.g. inflammatory cytokines: CCL2, CCL22, CCL7, and CCL17; markers of lung cancer: Mmp12, indicators of oxidative stress: Fabp4 and Noxo1) were also identified in this study, but again significant changes to gene regulation were only seen at exposure doses markedly higher than used here.\nThe above comparison supports a conclusion that nano-sized aerosols of CeO2NPs are more effective than micron-sized at generating effects. A few other in vivo inhalation studies have used nano-sized CeO2NPs aerosols, albeit with larger aerosols than used here (40 nm). For example, Demokritou et al. (2013) used a 90 nm aerosol and a similar study\ndesign (2.7mg/m3 2 h/d 4 d), resulting in a very similar exposure dose which generated significant neutrophilia and cell damage (LDH), similar to this study. Comparing the two studies, it is possible to argue that the levels of PMN infiltration and LDH are higher in the current study suggesting greater effects for the smaller aerosol; however, this may be a result of other factors including differences in the sacrifice time post-exposure (1 d versus 3 d). Morimoto et al. (2015) used an approximately nano-sized (90–110 nm) aerosol in a 28-d study (2 and 10mg/ m3) and found a pattern and degree of inflammatory effects at 3 and 7d post-exposure similar to the current study despite significantly greater levels of exposure, again suggesting a greater effect for the smaller aerosol particles. It is also interesting to note that Morimoto et al (2015) saw a reduction in effects between 3 and 7 d for some endpoints, which was not seen for our 2-week exposure. The results of our study are, therefore, broadly consistent with the small number of studies using nano-sized aerosols, but suggestive of a greater biological potency for our smaller aerosol.\nIt is generally understood that aerosol particle size influences the resulting biological effects following inhalation for a number of related reasons: level and pattern of deposition within the lung depends in detail on the aerosol particle size distribution in a non-linear manner, but with aerosol particles below 100 nm (peak around 20 nm) generally depositing more efficiently in the alveolar region than larger particles (Asgharian et al. 2009); smaller particles may also be less efficiently phagocytosed and, therefore, cleared from the lung than larger particles, thus leading potentially to prolonged exposure and build-up; and smaller particle size also implies a greater surface area per unit deposited mass, which a number of in vitro and in vivo studies have linked to greater toxicity (e.g. Oberd€orster et al. 2005; Stoeger et al. 2006). All these factors may have contributed to the greater apparent short-term toxicity of the aerosols used in this study in comparison with others in the literature.\nA generally accepted paradigm is that the toxicity of nanomaterials arises primarily as a result of their ability to generate reactive oxygen species (ROS) and thus oxidative stress damage (Fu et al. 2014). Studies have demonstrated that CeO2NPs can induce oxidative stress and resulting toxicity in vivo (Nemmar et al. 2017) and in vitro (Park et al. 2008b; Eom and Choi 2009). The hierarchical model of oxidative stress (Damoiseaux et al. 2011) proposes that cells and tissues respond to increasing levels of NP-induced oxidative stress via various enzyme systems - mild oxidative stress results in transcriptional activation of phase II antioxidant enzymes via nuclear factor (erythroid-derived 2)-like (Nrf2) induction; and at an intermediate level, redox-sensitive mitogen-activated protein kinase (MAPK) (family includes p38 MAPK and growth factor-regulated extracellular signal-related kinases (ERK)) and nuclear factor kappa-light-chain enhancer of activated B cells (NF-kappaB) cascades mount a pro-inflammatory response. Compatible with this hypothesis, in vitro studies have shown that CeO2NPs induce toxicity in human bronchial epithelial cells via oxidative stress and the p38-Nrf2 signaling pathway (Eom & Choi 2009) and in human hepatoma cells via oxidative stress and the activation of MAPK signaling pathways (Cheng et al. 2013). One of the significantly enriched terms in the Gene Ontology analysis of the 67 differentially expressed genes in this study (Supplementary Table S2) was GO:0070374 – positive regulation of ERK1 and ERK2 cascade, which is also consistent with the above model. MAPK pathways have also been shown to mediate toxicity for other nanomaterials, e.g. titanium dioxide (Park et al. 2008c) and other inhaled pollutants, e.g. cadmium (Cormet-Boyaka et al. 2012)."
    }, {
      "heading" : "Cerium speciation",
      "text" : "Cerium can exist in both 3þ and 4þ oxidation states. Typically the cerium in CeO2NPs is predominantly Ce4þ, however, surface defects mean that Ce3þ is also found at the surface, and indeed for CeO2NPs (3–30 nm) the majority of the surface ceria is Ce3þ (Deshpande et al. 2005). It has been hypothesized that initial differences in the Ce3þ/ Ce4þ ratio on the NP surface and changes to this following exposure may play a significant role in\ntoxicity determination (Auffan et al. 2009). In our study, to our knowledge the first to investigate cerium speciation in rat lung after inhalation exposure to CeO2NPs, analysis of the XANES cerium spectra (Figure 7) indicates that the cerium in the nanoparticles was largely Ce4þ; however, the cerium in the tissue samples was 15–21% Ce3þ, indicating a change in speciation following delivery to the lung. This speciation change is consistent with in vitro studies, which have indicated higher Ce3þ speciation inside rather than outside cells (Szymanski et al. 2015). Some studies have found that the presence of phosphate ions in aqueous systems significantly affects the reactivity of ceria and it has been hypothesized that the formation of cerium phosphate in biological systems would ‘trap’ cerium in the 3þ state and thus block potential cycling between Ce3þ and Ce4þ (Singh et al. 2011). Further studies are required to investigate the potential links between speciation and toxicity mechanisms, especially for long-term pulmonary effects, which, given the ability of CeO2NPs to generate ROS in a number of in vitro and in vivo systems (Lin et al. 2006; Park et al. 2008b; Nemmar et al. 2017) may relate to ROS generation capacity."
    }, {
      "heading" : "Lipidomic analysis",
      "text" : "The most abundant lipid classes in the lung lipidome are glycerophosphocholines (PC), due to their significant role in lung surfactant, glycerophosphoethanolamines (PE), glycerophosphoserines (PS), glycerolphosphoglycerols, and sphingolipids (Titz et al. 2016). Few studies have investigated the effect of inhaled nanomaterials on the lung lipidome and to date, all have been targeted. Gold nanoparticles (3- week exposure) had no effect on total lung surfactant, sphingolipids or glycerophospholipids, except a decrease in one PS species (Yu et al. 2007). Single-walled carbon nanotubes (4-d exposure) produced no changes in total phospholipids, no oxidized PC or PE species, but some oxidized minor phospholipid species, suggesting selective rather than nonspecific effects (Tyurina et al. 2011). Recently, alterations in numerous phosphorylcholine-containing lipid species were identified in rat lung following inhalation of ZnO particles (35 nm and 250 nm), with the analysis suggesting that these included lipids involved in membrane\nconformation and cellular signaling (Lee et al. 2016, 2018). In this study, untargeted mass spectrometrybased lipidomics revealed that the most marked effect of CeO2NP exposure is the significant increase of some lipids within the category of glycerophospholipids, dominated by PC and PE (Supplementary Tables S3 & S4 and Supplementary File SI1). Comparison of the putatively annotated lipids that were perturbed, with information on individual lipid species usually identified within the lung (Griese et al. 2015; Titz et al. 2016; Zemski Berry et al. 2017), revealed that the majority of the perturbed species were not those usually identified at significant concentrations within the lung. Comparing the annotated lipids against a comprehensive profile of lung glycerophospholipids suggests that of the 80 lipids listed by Zemski Berry et al. (2017) only three (PC(14:0/16:0), PC(16:0/16:1) and PE(16:0/18:1)) were significantly modified by CeO2NP exposure. The results of the global lipidomics analysis, the first to be undertaken for an in vivo nanotoxicology inhalation study, suggest minor changes to a small number of commonly found lipids within the lung, but potentially more marked changes to less abundant lipids, which may indicate effects for specific cells/ pathways. This could usefully be investigated further using a targeted analysis of these putatively annotated lipids.\nRelevance of aerosol concentration and characteristics\nCerium concentrations in ambient air in Newcastle (UK) post-introduction of EnviroxTM to local bus fleets were approximately 0.5 ng/m3 (Park et al. 2008a; Cassee et al. 2011; Gantt et al. 2015). A number of modeling studies have estimated potential future concentrations based on the more extensive use of the additives, including 1.25 103 ng/m3 (HEI 2001), 5–80 ng/m3 (Park et al. 2008a), and 22 ng/m3 (Erdakos et al. 2014). These concentrations are lower than used in this study (1.8 106 ng/m3), however, short-term exposures were used rather than the chronic exposures that would arise in the general population from the use of these fuel additives. Ma et al. (2011) estimated a lifetime lung burden of 936 mg/kg and Park et al. (2008a) estimated a 20-year lung burden of 30 mg. The doses delivered\nin our study were of this order, i.e. comparable to estimated lifetime exposure levels.\nLaboratory studies have found ceria particles emitted from various engines using CeO2NP fuel additives with a range of sizes, including: majority <80 nm (Skillas et al. 2000); ca. 75 nm (Gantt et al. 2015); and typically 60–300 nm (Dale et al. 2017), all broadly consistent with measurements made during field studies (5–100 nm) (Gantt et al. 2014) and with the size of the aerosol agglomerates used in this study. It is important to note, however, that emitted ceria particles are typically single crystals (or small groups thereof) formed within the engine from the smaller particles (8–10 nm) within the additive, rather than agglomerates as used here. This may impact on the resulting effects and could usefully be investigated further, but in this context it is important to note that studies using a range of sizes of primary particles producing aerosol agglomerates of a similar size have found that the resulting biological effects were very similar at concentrations below overload (Gosens et al. 2014; Keller et al. 2014), suggesting that aerosol particle size, rather than primary particle size, is a key factor driving biological effects. It is also necessary to acknowledge that in the environment some ceria particles would be attached to larger micron-sized soot particles, which may also affect their biological effects, although the importance of this is unclear with one study indicating 40% of ceria particles associated with larger soot particles (Gantt et al. 2015) but another suggesting significantly lower levels (Skillas et al. 2000).\nDiesel emissions are complex mixtures of gases and particles, and ultimately a complete assessment of the overall impact of using CeO2NP fuel additives on human health needs to consider all aspects of the changes in the emission characteristics (Zhang et al. 2013). Some studies have used diesel exhaust from machines using fuel additives. Cassee et al. (2012) exposed atherosclerosis-prone mice to exhaust from a diesel engine using standard fuel (DE) or fuel containing CeO2NP (DECe) and found a trend of increasing atherosclerotic plaques following DE exposure that was not evident in the DCeE group. Overall there were no clear pathological changes in either group. These results contrast with those of Snow et al. (2014), who exposed rats to diesel exhaust (DE) from a generator run using\ndiesel fuel, with (DECe) and without (DE) the addition of CeO2NP and found that DECe induced greater adverse pulmonary effects. Clearly such studies are extremely useful in evaluating the overall effects of the introduction of CeO2NP fuel additives, however, the influence of engine type, engine abatement, running conditions, and exhaust ageing may be significant in determining the characteristics of the output. Thus, studies investigating the biological effects of relevant CeO2NPs remain of use in understanding their contribution to overall effects."
    }, {
      "heading" : "Conclusions",
      "text" : "Short-term inhalation exposure to nano-sized cerium oxide agglomerates induced a significant pulmonary inflammatory effect with a limited resolution by 7 d post-exposure, indicating the potential for longer-term effects, which is worthy of further investigation. Comparison with the results of previous studies using larger aerosol particle sizes supports a hypothesis that aerosol particle size is a key toxicity driver and thus emphasizes the need for future in vivo inhalation studies to use nanomaterial aerosol sizes of environmental relevance."
    }, {
      "heading" : "Acknowledgements",
      "text" : "The authors thank Dr Jennifer Kirwan and Lorraine Wallace (University of Birmingham) for assistance with the multiomics data collection. Transmission electron microscopy was performed by Mr Lennell Reynolds at the Northwestern University Center for Advanced Microscopy, generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The authors thank Diamond Light Source for access to beamline I18 (proposal SP12583-1) that contributed to the results presented here."
    }, {
      "heading" : "Disclosure statement",
      "text" : "The authors report no conflict of interests with the work in this article. The authors alone are responsible for the content and writing of the manuscript."
    }, {
      "heading" : "Funding",
      "text" : "This study was funded by the UK’s Natural Environment Research Council and Medical Research Council as part of the FABLE project (From Airborne exposures to BioLogical Effects) (NE/I008314), with support from Public Health England."
    } ],
    "references" : [ {
      "title" : "Toxicity and Bio-accumulation of Inhaled Cerium Oxide Nanoparticles in CD1 Mice.",
      "author" : [ "S. Aalapati", "S. Ganapathy", "S. Manapuram", "G. Anumolu", "B.M. Prakya" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "Aalapati et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Aalapati et al\\.",
      "year" : 2014
    }, {
      "title" : "MPPD, Multiple-Path Dosimetry Model v2.11",
      "author" : [ "B. Asgharian", "O. Price", "F. Miller", "R. Subramaniam", "F.R. Cassee", "J. Freijer", "L. Van Bree", "R. De Winter-Sorkina" ],
      "venue" : "Applied Research Associates (ARA), The Hamner Institutes for Health Sciences,",
      "citeRegEx" : "Asgharian et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Asgharian et al\\.",
      "year" : 2009
    }, {
      "title" : "CeO2 Nanoparticles Induce DNA Damage towards Human Dermal Fibroblasts in Vitro.",
      "author" : [ "M. Auffan", "J. Rose", "T. Orsiere", "M. De Meo", "A. Thill", "O. Zeyons", "O. Proux" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "Auffan et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Auffan et al\\.",
      "year" : 2009
    }, {
      "title" : "Identification of the Appropriate Dose Metric for Pulmonary Inflammation of Silver Nanoparticles in an Inhalation Toxicity Study.",
      "author" : [ "H.M. Braakhuis", "F.R. Cassee", "P.H. Fokkens", "L.J. De La Fonteyne", "A.G. Oomen", "P. Krystek", "W.H. De Jong", "H. Van Loveren", "M.V. Park" ],
      "venue" : null,
      "citeRegEx" : "Braakhuis et al\\.,? \\Q2016\\E",
      "shortCiteRegEx" : "Braakhuis et al\\.",
      "year" : 2016
    }, {
      "title" : "Exposure, health and",
      "author" : [ "J. Weinstein", "K. Dreher" ],
      "venue" : null,
      "citeRegEx" : "Weinstein and Dreher.,? \\Q2011\\E",
      "shortCiteRegEx" : "Weinstein and Dreher.",
      "year" : 2011
    }, {
      "title" : "No Time to Lose – High Throughput",
      "author" : [ "T. Xia" ],
      "venue" : null,
      "citeRegEx" : "Xia,? \\Q2011\\E",
      "shortCiteRegEx" : "Xia",
      "year" : 2011
    }, {
      "title" : "An in Vivo",
      "author" : [ "Goldsmith", "W. Mckinney", "D. Frazer" ],
      "venue" : null,
      "citeRegEx" : "Goldsmith et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Goldsmith et al\\.",
      "year" : 2013
    }, {
      "title" : "Oxidative Stress of CeO2",
      "author" : [ "H.J. 2061873. Eom", "J. Choi" ],
      "venue" : null,
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2009
    }, {
      "title" : "Tissue Distribution of Inhaled Micro",
      "author" : [ "F.R. Cassee" ],
      "venue" : null,
      "citeRegEx" : "Cassee.,? \\Q2012\\E",
      "shortCiteRegEx" : "Cassee.",
      "year" : 2012
    }, {
      "title" : "Comparative Hazard Identification of Nanoand Micro-sized Cerium Oxide Particles Based on 28-day Inhalation Studies in Rats.",
      "author" : [ "I. Gosens", "L.E. Mathijssen", "B.G. Bokkers", "H. Muijser", "F.R. Cassee" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "Gosens et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Gosens et al\\.",
      "year" : 2014
    }, {
      "title" : "Surfactant Lipidomics in Healthy Children and Childhood Interstitial Lung Disease.",
      "author" : [ "uckler", "G. Schmitz", "R. Zarbock" ],
      "venue" : "PLoS One",
      "citeRegEx" : "uckler et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "uckler et al\\.",
      "year" : 2015
    }, {
      "title" : "Evaluation of Human Health Risk from Cerium Added to Diesel Fuel",
      "author" : [ "HEI" ],
      "venue" : "Communication 9. Boston, MA: Health Effects Institute (HEI).",
      "citeRegEx" : "HEI,? 2001",
      "shortCiteRegEx" : "HEI",
      "year" : 2001
    }, {
      "title" : "Time Course of Lung Retention and Toxicity of Inhaled Particles: Short-term Exposure to nano-Ceria.",
      "author" : [ "J. Keller", "W. Wohlleben", "L. Ma-Hock", "V. Strauss", "S. Groters", "K. Kuttler", "K. Wiench" ],
      "venue" : "Archives of Toxicology",
      "citeRegEx" : "Keller et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Keller et al\\.",
      "year" : 2014
    }, {
      "title" : "LC-MS-based Lipidomics",
      "author" : [ "Cheng", "C.Y. Lin" ],
      "venue" : null,
      "citeRegEx" : "Cheng and Lin.,? \\Q2018\\E",
      "shortCiteRegEx" : "Cheng and Lin.",
      "year" : 2018
    }, {
      "title" : "2016. “In Vivo Biodistribution",
      "author" : [ "O. Jolliet" ],
      "venue" : null,
      "citeRegEx" : "Jolliet.,? \\Q2016\\E",
      "shortCiteRegEx" : "Jolliet.",
      "year" : 2016
    }, {
      "title" : "Pulmonary Toxicity",
      "author" : [ "T. Myojo", "K. Kawai" ],
      "venue" : null,
      "citeRegEx" : "Myojo and Kawai,? \\Q2015\\E",
      "shortCiteRegEx" : "Myojo and Kawai",
      "year" : 2015
    }, {
      "title" : "Cerium Oxide Nanoparticles in Lung Acutely",
      "author" : [ "Ali" ],
      "venue" : null,
      "citeRegEx" : "2017.,? \\Q2017\\E",
      "shortCiteRegEx" : "2017.",
      "year" : 2017
    }, {
      "title" : "Correlation between Particle Size, in Vivo Particle Persistence, and Lung Injury.",
      "author" : [ "G. orster", "J. Ferin", "B.E. Lehnert" ],
      "venue" : "Environmental Health Perspectives",
      "citeRegEx" : "orster et al\\.,? \\Q1994\\E",
      "shortCiteRegEx" : "orster et al\\.",
      "year" : 1994
    }, {
      "title" : "Hazard and Risk Assessment",
      "author" : [ "J.P. Morin" ],
      "venue" : null,
      "citeRegEx" : "Morin,? \\Q2008\\E",
      "shortCiteRegEx" : "Morin",
      "year" : 2008
    }, {
      "title" : "Exploring the Properties",
      "author" : [ "Klaessig", "B. Stadler" ],
      "venue" : null,
      "citeRegEx" : "Klaessig and Stadler.,? \\Q2014\\E",
      "shortCiteRegEx" : "Klaessig and Stadler.",
      "year" : 2014
    }, {
      "title" : "Cerium Oxide",
      "author" : [ "C. Dasenbrock", "O. Creutzenberg" ],
      "venue" : null,
      "citeRegEx" : "Dasenbrock and Creutzenberg.,? \\Q2018\\E",
      "shortCiteRegEx" : "Dasenbrock and Creutzenberg.",
      "year" : 2018
    }, {
      "title" : "A Phosphate-dependent Shift in Redox",
      "author" : [ "W.T. Self" ],
      "venue" : null,
      "citeRegEx" : "Self.,? \\Q2011\\E",
      "shortCiteRegEx" : "Self.",
      "year" : 2011
    }, {
      "title" : "Instillation of Six",
      "author" : [ "B. Ritter", "J. Heyder", "H. Schulz" ],
      "venue" : null,
      "citeRegEx" : "Ritter et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Ritter et al\\.",
      "year" : 2006
    }, {
      "title" : "Molecular Toxicity of Cerium",
      "author" : [ "Lead", "M.R. Viant" ],
      "venue" : null,
      "citeRegEx" : "Lead and Viant.,? \\Q2016\\E",
      "shortCiteRegEx" : "Lead and Viant.",
      "year" : 2016
    }, {
      "title" : "Effects of Cigarette",
      "author" : [ "Schneider", "C. Nury" ],
      "venue" : null,
      "citeRegEx" : "Schneider and Nury,? \\Q2016\\E",
      "shortCiteRegEx" : "Schneider and Nury",
      "year" : 2016
    }, {
      "title" : "Translocation and Effects of Gold",
      "author" : [ "W.-Y. Ong" ],
      "venue" : null,
      "citeRegEx" : "Ong.,? \\Q2007\\E",
      "shortCiteRegEx" : "Ong.",
      "year" : 2007
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "A number of in vivo inhalation studies have also reported similar effects, with indications that pulmonary inflammatory responses are slow to resolve post-exposure (Aalapati et al. 2014).",
      "startOffset" : 164,
      "endOffset" : 186
    }, {
      "referenceID" : 3,
      "context" : "However, to date, the majority of reported CeO2NP inhalation studies, as summarized in Table 1, including those mentioned above, have used aerosols in the micron-size range or at the upper end of the nano-size range and therefore, given the importance of particle size in driving biological effects (Oberd€ orster, Ferin, & Lehnert 1994; Braakhuis et al. 2016), may not be directly relevant to a hazard assessment of the effect of ceria particles emitted from engines using CeO2NP fuel additives.",
      "startOffset" : 299,
      "endOffset" : 360
    }, {
      "referenceID" : 2,
      "context" : "CeO2NPs are an interesting case as it has been hypothesized that initial differences in the Ce3þ/ Ce4þ ratio on the NP surface, and changes in their anti-oxidant potential following exposure, may play a significant role in toxicity determination (Auffan et al. 2009).",
      "startOffset" : 246,
      "endOffset" : 266
    }, {
      "referenceID" : 7,
      "context" : "We have investigated the pulmonary toxicity of nano-sized CeO2NP aerosol agglomerate particles (CMD approximately 40 nm, GSD 1.7; primary particle size 5–10 nm). Histopathology indicated mild inflammation with alveolar epithelial hyperplasia (Figure 4), which increased with time after exposure, suggesting the potential for long-term effects. Consistent with this the BALF analysis indicates a significant inflammatory response increasing between 3 and 7 d (Figure 2 and Supplementary Figures S2 and S3). These changes were matched by significant increases in cytokines involved in inflammatory cell infiltration, such as CXCL1(CINC-1) and CCL2(MCP-1) (Figure 3), with levels increasing with dose for each post inhalation time (dosedependence). Concentrations of total protein, LDH, and ALP in BALF increased significantly for all groups exposed to CeO2NP aerosols (Figure 2 and Supplementary Figures S3) with some evidence of recovery only for the 1-week exposures, again suggesting the potential for longer-term effects. The gene expression results (Supplementary Table S2) are consistent with the above, with significant Gene Ontology terms including (GO:0030593) neutrophil chemotaxis, (GO:0048247) lymphocyte chemotaxis, (GO:0008009) chemokine activity, and (GO:0002548) monocyte chemotaxis. Other CeO2NP inhalation studies have also shown lung inflammation, cytotoxicity, and airblood barrier damage;, however, the majority of such studies have used aerosols with micron-sized aerosol agglomerates (Table 1), significantly larger than used in this study, and the resulting effects are typically less marked than indicated here. To achieve similar or relatively comparable toxicological effects, inhalation studies with micron-sized CeO2NP aerosols usually used higher aerosol concentrations or longer exposure durations (Table 1). Landsiedel et al. (2014), for example, used a similar short-term repeated exposure study design (6 h/d for 5 d with sacrifice at 3 d) with a micron-sized aerosol, which at the low concentration (0.",
      "startOffset" : 125,
      "endOffset" : 1863
    }, {
      "referenceID" : 1,
      "context" : "It is generally understood that aerosol particle size influences the resulting biological effects following inhalation for a number of related reasons: level and pattern of deposition within the lung depends in detail on the aerosol particle size distribution in a non-linear manner, but with aerosol particles below 100 nm (peak around 20 nm) generally depositing more efficiently in the alveolar region than larger particles (Asgharian et al. 2009); smaller particles may also be less efficiently phagocytosed and, therefore, cleared from the lung than larger particles, thus leading potentially to prolonged exposure and build-up; and smaller particle size also implies a greater surface area per unit deposited mass, which a number of in vitro and in vivo studies have linked to greater toxicity (e.",
      "startOffset" : 427,
      "endOffset" : 450
    }, {
      "referenceID" : 9,
      "context" : "their results at this concentration indicate a significantly lower response, with small but significant changes for only three endpoints, including neutrophil and lymphocyte number but not LDH. Only at the medium and high concentrations, delivering exposure doses >4 times higher, were significant changes seen, similar to those here. Keller et al. (2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study.",
      "startOffset" : 1,
      "endOffset" : 356
    }, {
      "referenceID" : 6,
      "context" : "(2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study. However, it was only at the medium and high concentrations, delivering exposure doses >5 times higher than our study, that a broad pattern of changes was seen, similar to the results presented here. It is clearly more difficult to make direct comparisons with the results from studies with longer exposure durations; however, it is instructive to note that levels of CCL2(MCP-1), which were significantly enhanced in this study, were only significantly enhanced in a 28-d study (6 h/d, 5 d/ week, 4weeks) (Schwotzer et al. 2017, 2018) at the two highest concentration levels, which would have resulted in exposure doses >3 times higher than this study, and for neutrophil numbers and LDH levels only the highest concentration (3mg/m(3)), delivering an exposure dose 9 times greater, produced similar effects to those reported here. Schwotzer et al. (2018) also assessed the effect of exposure on the expression of 391 genes in alveolar epithelial type II cells and identified significant regulatory changes to a total of 30 genes, many of which (e.",
      "startOffset" : 3,
      "endOffset" : 1034
    }, {
      "referenceID" : 6,
      "context" : "(2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study. However, it was only at the medium and high concentrations, delivering exposure doses >5 times higher than our study, that a broad pattern of changes was seen, similar to the results presented here. It is clearly more difficult to make direct comparisons with the results from studies with longer exposure durations; however, it is instructive to note that levels of CCL2(MCP-1), which were significantly enhanced in this study, were only significantly enhanced in a 28-d study (6 h/d, 5 d/ week, 4weeks) (Schwotzer et al. 2017, 2018) at the two highest concentration levels, which would have resulted in exposure doses >3 times higher than this study, and for neutrophil numbers and LDH levels only the highest concentration (3mg/m(3)), delivering an exposure dose 9 times greater, produced similar effects to those reported here. Schwotzer et al. (2018) also assessed the effect of exposure on the expression of 391 genes in alveolar epithelial type II cells and identified significant regulatory changes to a total of 30 genes, many of which (e.g. inflammatory cytokines: CCL2, CCL22, CCL7, and CCL17; markers of lung cancer: Mmp12, indicators of oxidative stress: Fabp4 and Noxo1) were also identified in this study, but again significant changes to gene regulation were only seen at exposure doses markedly higher than used here. The above comparison supports a conclusion that nano-sized aerosols of CeO2NPs are more effective than micron-sized at generating effects. A few other in vivo inhalation studies have used nano-sized CeO2NPs aerosols, albeit with larger aerosols than used here (40 nm). For example, Demokritou et al. (2013) used a 90 nm aerosol and a similar study design (2.",
      "startOffset" : 3,
      "endOffset" : 1820
    }, {
      "referenceID" : 6,
      "context" : "(2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study. However, it was only at the medium and high concentrations, delivering exposure doses >5 times higher than our study, that a broad pattern of changes was seen, similar to the results presented here. It is clearly more difficult to make direct comparisons with the results from studies with longer exposure durations; however, it is instructive to note that levels of CCL2(MCP-1), which were significantly enhanced in this study, were only significantly enhanced in a 28-d study (6 h/d, 5 d/ week, 4weeks) (Schwotzer et al. 2017, 2018) at the two highest concentration levels, which would have resulted in exposure doses >3 times higher than this study, and for neutrophil numbers and LDH levels only the highest concentration (3mg/m(3)), delivering an exposure dose 9 times greater, produced similar effects to those reported here. Schwotzer et al. (2018) also assessed the effect of exposure on the expression of 391 genes in alveolar epithelial type II cells and identified significant regulatory changes to a total of 30 genes, many of which (e.g. inflammatory cytokines: CCL2, CCL22, CCL7, and CCL17; markers of lung cancer: Mmp12, indicators of oxidative stress: Fabp4 and Noxo1) were also identified in this study, but again significant changes to gene regulation were only seen at exposure doses markedly higher than used here. The above comparison supports a conclusion that nano-sized aerosols of CeO2NPs are more effective than micron-sized at generating effects. A few other in vivo inhalation studies have used nano-sized CeO2NPs aerosols, albeit with larger aerosols than used here (40 nm). For example, Demokritou et al. (2013) used a 90 nm aerosol and a similar study design (2.7mg/m(3) 2 h/d 4 d), resulting in a very similar exposure dose which generated significant neutrophilia and cell damage (LDH), similar to this study. Comparing the two studies, it is possible to argue that the levels of PMN infiltration and LDH are higher in the current study suggesting greater effects for the smaller aerosol; however, this may be a result of other factors including differences in the sacrifice time post-exposure (1 d versus 3 d). Morimoto et al. (2015) used an approximately nano-sized (90–110 nm) aerosol in a 28-d study (2 and 10mg/ m(3)) and found a pattern and degree of inflammatory effects at 3 and 7d post-exposure similar to the current study despite significantly greater levels of exposure, again suggesting a greater effect for the smaller aerosol particles.",
      "startOffset" : 3,
      "endOffset" : 2346
    }, {
      "referenceID" : 6,
      "context" : "(2014) also used a micron-sized aerosol in a shortterm repeated dose study using three concentrations, the lowest of which delivered a similar exposure dose to our 1-week study. However, it was only at the medium and high concentrations, delivering exposure doses >5 times higher than our study, that a broad pattern of changes was seen, similar to the results presented here. It is clearly more difficult to make direct comparisons with the results from studies with longer exposure durations; however, it is instructive to note that levels of CCL2(MCP-1), which were significantly enhanced in this study, were only significantly enhanced in a 28-d study (6 h/d, 5 d/ week, 4weeks) (Schwotzer et al. 2017, 2018) at the two highest concentration levels, which would have resulted in exposure doses >3 times higher than this study, and for neutrophil numbers and LDH levels only the highest concentration (3mg/m(3)), delivering an exposure dose 9 times greater, produced similar effects to those reported here. Schwotzer et al. (2018) also assessed the effect of exposure on the expression of 391 genes in alveolar epithelial type II cells and identified significant regulatory changes to a total of 30 genes, many of which (e.g. inflammatory cytokines: CCL2, CCL22, CCL7, and CCL17; markers of lung cancer: Mmp12, indicators of oxidative stress: Fabp4 and Noxo1) were also identified in this study, but again significant changes to gene regulation were only seen at exposure doses markedly higher than used here. The above comparison supports a conclusion that nano-sized aerosols of CeO2NPs are more effective than micron-sized at generating effects. A few other in vivo inhalation studies have used nano-sized CeO2NPs aerosols, albeit with larger aerosols than used here (40 nm). For example, Demokritou et al. (2013) used a 90 nm aerosol and a similar study design (2.7mg/m(3) 2 h/d 4 d), resulting in a very similar exposure dose which generated significant neutrophilia and cell damage (LDH), similar to this study. Comparing the two studies, it is possible to argue that the levels of PMN infiltration and LDH are higher in the current study suggesting greater effects for the smaller aerosol; however, this may be a result of other factors including differences in the sacrifice time post-exposure (1 d versus 3 d). Morimoto et al. (2015) used an approximately nano-sized (90–110 nm) aerosol in a 28-d study (2 and 10mg/ m(3)) and found a pattern and degree of inflammatory effects at 3 and 7d post-exposure similar to the current study despite significantly greater levels of exposure, again suggesting a greater effect for the smaller aerosol particles. It is also interesting to note that Morimoto et al (2015) saw a reduction in effects between 3 and 7 d for some endpoints, which was not seen for our 2-week exposure.",
      "startOffset" : 3,
      "endOffset" : 2721
    }, {
      "referenceID" : 2,
      "context" : "It has been hypothesized that initial differences in the Ce3þ/ Ce4þ ratio on the NP surface and changes to this following exposure may play a significant role in toxicity determination (Auffan et al. 2009).",
      "startOffset" : 185,
      "endOffset" : 205
    }, {
      "referenceID" : 7,
      "context" : "2016, 2018). In this study, untargeted mass spectrometrybased lipidomics revealed that the most marked effect of CeO2NP exposure is the significant increase of some lipids within the category of glycerophospholipids, dominated by PC and PE (Supplementary Tables S3 & S4 and Supplementary File SI1). Comparison of the putatively annotated lipids that were perturbed, with information on individual lipid species usually identified within the lung (Griese et al. 2015; Titz et al. 2016; Zemski Berry et al. 2017), revealed that the majority of the perturbed species were not those usually identified at significant concentrations within the lung. Comparing the annotated lipids against a comprehensive profile of lung glycerophospholipids suggests that of the 80 lipids listed by Zemski Berry et al. (2017) only three (PC(14:0/16:0), PC(16:0/16:1) and PE(16:0/18:1)) were significantly modified by CeO2NP exposure.",
      "startOffset" : 2,
      "endOffset" : 805
    }, {
      "referenceID" : 11,
      "context" : "25 10(3) ng/m(3) (HEI 2001), 5–80 ng/m(3) (Park et al.",
      "startOffset" : 17,
      "endOffset" : 27
    }, {
      "referenceID" : 9,
      "context" : "This may impact on the resulting effects and could usefully be investigated further, but in this context it is important to note that studies using a range of sizes of primary particles producing aerosol agglomerates of a similar size have found that the resulting biological effects were very similar at concentrations below overload (Gosens et al. 2014; Keller et al. 2014), suggesting that aerosol particle size, rather than primary particle size, is a key factor driving biological effects.",
      "startOffset" : 335,
      "endOffset" : 375
    }, {
      "referenceID" : 12,
      "context" : "This may impact on the resulting effects and could usefully be investigated further, but in this context it is important to note that studies using a range of sizes of primary particles producing aerosol agglomerates of a similar size have found that the resulting biological effects were very similar at concentrations below overload (Gosens et al. 2014; Keller et al. 2014), suggesting that aerosol particle size, rather than primary particle size, is a key factor driving biological effects.",
      "startOffset" : 335,
      "endOffset" : 375
    }, {
      "referenceID" : 7,
      "context" : "2011; Gantt et al. 2015). A number of modeling studies have estimated potential future concentrations based on the more extensive use of the additives, including 1.25 10(3) ng/m(3) (HEI 2001), 5–80 ng/m(3) (Park et al. 2008a), and 22 ng/m(3) (Erdakos et al. 2014). These concentrations are lower than used in this study (1.8 10(6) ng/m(3)), however, short-term exposures were used rather than the chronic exposures that would arise in the general population from the use of these fuel additives. Ma et al. (2011) estimated a lifetime lung burden of 936 mg/kg and Park et al.",
      "startOffset" : 2,
      "endOffset" : 513
    }, {
      "referenceID" : 7,
      "context" : "2011; Gantt et al. 2015). A number of modeling studies have estimated potential future concentrations based on the more extensive use of the additives, including 1.25 10(3) ng/m(3) (HEI 2001), 5–80 ng/m(3) (Park et al. 2008a), and 22 ng/m(3) (Erdakos et al. 2014). These concentrations are lower than used in this study (1.8 10(6) ng/m(3)), however, short-term exposures were used rather than the chronic exposures that would arise in the general population from the use of these fuel additives. Ma et al. (2011) estimated a lifetime lung burden of 936 mg/kg and Park et al. (2008a) estimated a 20-year lung burden of 30 mg.",
      "startOffset" : 2,
      "endOffset" : 583
    }, {
      "referenceID" : 7,
      "context" : "2011; Gantt et al. 2015). A number of modeling studies have estimated potential future concentrations based on the more extensive use of the additives, including 1.25 10(3) ng/m(3) (HEI 2001), 5–80 ng/m(3) (Park et al. 2008a), and 22 ng/m(3) (Erdakos et al. 2014). These concentrations are lower than used in this study (1.8 10(6) ng/m(3)), however, short-term exposures were used rather than the chronic exposures that would arise in the general population from the use of these fuel additives. Ma et al. (2011) estimated a lifetime lung burden of 936 mg/kg and Park et al. (2008a) estimated a 20-year lung burden of 30 mg. The doses delivered in our study were of this order, i.e. comparable to estimated lifetime exposure levels. Laboratory studies have found ceria particles emitted from various engines using CeO2NP fuel additives with a range of sizes, including: majority <80 nm (Skillas et al. 2000); ca. 75 nm (Gantt et al. 2015); and typically 60–300 nm (Dale et al. 2017), all broadly consistent with measurements made during field studies (5–100 nm) (Gantt et al. 2014) and with the size of the aerosol agglomerates used in this study. It is important to note, however, that emitted ceria particles are typically single crystals (or small groups thereof) formed within the engine from the smaller particles (8–10 nm) within the additive, rather than agglomerates as used here. This may impact on the resulting effects and could usefully be investigated further, but in this context it is important to note that studies using a range of sizes of primary particles producing aerosol agglomerates of a similar size have found that the resulting biological effects were very similar at concentrations below overload (Gosens et al. 2014; Keller et al. 2014), suggesting that aerosol particle size, rather than primary particle size, is a key factor driving biological effects. It is also necessary to acknowledge that in the environment some ceria particles would be attached to larger micron-sized soot particles, which may also affect their biological effects, although the importance of this is unclear with one study indicating 40% of ceria particles associated with larger soot particles (Gantt et al. 2015) but another suggesting significantly lower levels (Skillas et al. 2000). Diesel emissions are complex mixtures of gases and particles, and ultimately a complete assessment of the overall impact of using CeO2NP fuel additives on human health needs to consider all aspects of the changes in the emission characteristics (Zhang et al. 2013). Some studies have used diesel exhaust from machines using fuel additives. Cassee et al. (2012) exposed atherosclerosis-prone mice to exhaust from a diesel engine using standard fuel (DE) or fuel containing CeO2NP (DECe) and found a trend of increasing atherosclerotic plaques following DE exposure that was not evident in the DCeE group.",
      "startOffset" : 2,
      "endOffset" : 2654
    }, {
      "referenceID" : 7,
      "context" : "2011; Gantt et al. 2015). A number of modeling studies have estimated potential future concentrations based on the more extensive use of the additives, including 1.25 10(3) ng/m(3) (HEI 2001), 5–80 ng/m(3) (Park et al. 2008a), and 22 ng/m(3) (Erdakos et al. 2014). These concentrations are lower than used in this study (1.8 10(6) ng/m(3)), however, short-term exposures were used rather than the chronic exposures that would arise in the general population from the use of these fuel additives. Ma et al. (2011) estimated a lifetime lung burden of 936 mg/kg and Park et al. (2008a) estimated a 20-year lung burden of 30 mg. The doses delivered in our study were of this order, i.e. comparable to estimated lifetime exposure levels. Laboratory studies have found ceria particles emitted from various engines using CeO2NP fuel additives with a range of sizes, including: majority <80 nm (Skillas et al. 2000); ca. 75 nm (Gantt et al. 2015); and typically 60–300 nm (Dale et al. 2017), all broadly consistent with measurements made during field studies (5–100 nm) (Gantt et al. 2014) and with the size of the aerosol agglomerates used in this study. It is important to note, however, that emitted ceria particles are typically single crystals (or small groups thereof) formed within the engine from the smaller particles (8–10 nm) within the additive, rather than agglomerates as used here. This may impact on the resulting effects and could usefully be investigated further, but in this context it is important to note that studies using a range of sizes of primary particles producing aerosol agglomerates of a similar size have found that the resulting biological effects were very similar at concentrations below overload (Gosens et al. 2014; Keller et al. 2014), suggesting that aerosol particle size, rather than primary particle size, is a key factor driving biological effects. It is also necessary to acknowledge that in the environment some ceria particles would be attached to larger micron-sized soot particles, which may also affect their biological effects, although the importance of this is unclear with one study indicating 40% of ceria particles associated with larger soot particles (Gantt et al. 2015) but another suggesting significantly lower levels (Skillas et al. 2000). Diesel emissions are complex mixtures of gases and particles, and ultimately a complete assessment of the overall impact of using CeO2NP fuel additives on human health needs to consider all aspects of the changes in the emission characteristics (Zhang et al. 2013). Some studies have used diesel exhaust from machines using fuel additives. Cassee et al. (2012) exposed atherosclerosis-prone mice to exhaust from a diesel engine using standard fuel (DE) or fuel containing CeO2NP (DECe) and found a trend of increasing atherosclerotic plaques following DE exposure that was not evident in the DCeE group. Overall there were no clear pathological changes in either group. These results contrast with those of Snow et al. (2014), who exposed rats to diesel exhaust (DE) from a generator run using 14 C.",
      "startOffset" : 2,
      "endOffset" : 3019
    } ],
    "year" : 2019,
    "abstractText" : "Cerium oxide nanoparticles (CeO2NPs), used in some diesel fuel additives to improve fuel combustion efficiency and exhaust filter operation, have been detected in ambient air and concerns have been raised about their potential human health impact. The majority of CeO2NP inhalation studies undertaken to date have used aerosol particles of larger sizes than the evidence suggests are emitted from vehicles using such fuel additives. Hence, the objective of this study was to investigate the effects of inhaled CeO2NP aerosols of a more environmentally relevant size, utilizing a combination of methods, including untargeted multi-omics to enable the broadest possible survey of molecular responses and synchrotron X-ray spectroscopy to investigate cerium speciation. Male Sprague–Dawley rats were exposed by nose-only inhalation to aerosolized CeO2NPs (mass concentration 1.8mg/m, aerosol count median diameter 40nm) for 3h/d for 4 d/week, for 1 or 2 weeks and sacrificed at 3 and 7d post-exposure. Markers of inflammation changed significantly in a doseand time-dependent manner, which, combined with results from lung histopathology and gene expression analyses suggest an inflammatory response greater than that seen in studies using micron-sized ceria aerosols. Lipidomics of lung tissue revealed changes to minor lipid species, implying specific rather than general cellular effects. Cerium speciation analysis indicated a change in Ce3þ/Ce4þ ratio within lung tissue. Collectively, these results in conjunction with earlier studies emphasize the importance of aerosol particle size on toxicity determination. Furthermore, the limited effect resolution within 7d suggested the possibility of longer-term effects. ARTICLE HISTORY Received 3 July 2018 Revised 27 November 2018 Accepted 28 November 2018",
    "creator" : null
  }
}